Search
IR501
go.drugbank.com/drugs/DB06464ExperimentalIR501 (Ravax) is a potential first-in-class vaccine for the treatment of Rheumatoid Arthritis. It specifically targets autoreactive T-cells, reducing their activity. … It was last known to be in phase III clinical trials.
Hu-PHEC Liver
go.drugbank.com/drugs/DB18347ExperimentalHu-PHEC Liver is an adult hemogenic endothelial cells.
NN-8828
go.drugbank.com/drugs/DB18361InvestigationalNN-8828 is an anti-interleukin 21 monoclonal antibody.
AVE9633
go.drugbank.com/drugs/DB06318InvestigationalAVE9633 is an anti-CD33 monoclonal antibody-DM4 conjugate.
NS-2359
go.drugbank.com/drugs/DB05805InvestigationalNS2359 is a triple monoamine re-uptake inhibitor with a new, unique drug profile expected to yield important benefits compared to existing treatments of depression. … This mode of action is expected to produce an optimal reduction in all disease symptoms and the possibility of an earlier onset of action compared to antidepressants already on the market.
Camptothecin
go.drugbank.com/drugs/DB04690InvestigationalCamptothecin is an alkaloid isolated from the stem wood of the Chinese tree, <i>Camptotheca acuminata</i>. This compound selectively inhibits the nuclear enzyme DNA topoisomerase, type I.
ACT-101
go.drugbank.com/drugs/DB17000ExperimentalACT-101 is a recombinant human alpha-fetoprotein or rhAFP.
Synonyms: ACT 101RAPA-201
go.drugbank.com/drugs/DB18446InvestigationalRAPA-201 is an autologous rapamycin-resistant T-cell therapy.
Synonyms: Rapamycin-resistant autologous Th1/Tc1 T-cellsAMT-101
go.drugbank.com/drugs/DB18555InvestigationalAMT-101 is a recombinant human interleukin-10 fusion protein.